Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹16 Cr
Revenue (TTM)
₹11 Cr
Net Profit (TTM)
₹0 Cr
ROE
0.9 %
ROCE
4 %
P/E Ratio
35.3
P/B Ratio
2.1
Industry P/E
44.74
EV/EBITDA
19.2
Div. Yield
0 %
Debt to Equity
0
Book Value
₹1.4
EPS
₹0.1
Face value
1
Shares outstanding
53,739,000
CFO
₹4.12 Cr
EBITDA
₹2.30 Cr
Net Profit
₹1.61 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zenith Health Care
| -10.7 | -9.4 | -12.1 | -30.3 | -9.1 | -11.7 | 12.9 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zenith Health Care
| -37.1 | -4.3 | 3.4 | -42.9 | -10.2 | 622.2 | -53.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zenith Health Care
|
3.0 | 16.1 | 11.3 | 0.5 | 0.6 | 6.1 | 35.3 | 2.1 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Zenith Healthcare Limited manufactures, sells, and exports pharmaceutical formulations in India. The company offers products in the form of tablets, capsules, oral liquids, and injections in various therapeutic areas. It also engages in the contract... manufacturing of various dosage forms. The company also supplies medicines to Cambodia, Myanmar, Papa New Guinea, Sri Lanka, Kenya, Nigeria, Gambia, Zambia, Namibia, Botswana, Armenia, Georgia, Uzbekistan, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen, and Turkey. Zenith Healthcare Limited was founded in 1994 and is based in Ahmedabad, India. Read more
Incorporated
1994
Chairman
Mahendra C Raycha
Managing Director
Mahendra C Raycha
Headquarters
Ahmedabad, Gujarat
Website
Annual Reports
The share price of Zenith Health Care Ltd is ₹2.99 (BSE) as of 02-Apr-2026 IST. Zenith Health Care Ltd has given a return of -9.09% in the last 3 years.
The P/E ratio of Zenith Health Care Ltd is 35.31 times as on 02-Apr-2026, a 21 discount to its peers’ median range of 44.74 times.
The P/B ratio of Zenith Health Care Ltd is 2.07 times as on 02-Apr-2026, a 33 discount to its peers’ median range of 3.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
334.40
|
3.03
|
|
2024
|
108.53
|
3.01
|
|
2023
|
274.48
|
2.96
|
|
2022
|
123.36
|
5.36
|
|
2021
|
69.26
|
4.45
|
The 52-week high and low of Zenith Health Care Ltd are Rs 5.15 and Rs 2.23 as of 05-Apr-2026.
Zenith Health Care Ltd has a market capitalisation of ₹ 16 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Zenith Health Care Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.